Table 1.
Study | Patients | No. of stents | Stent duration, mo | No. of ERC | F/U duration, mo | Resolution of AS, n (%) | Recurrence of AS, n (%) | Complications |
---|---|---|---|---|---|---|---|---|
Rerknimitr et al. (2002) [19] | 43 | 2.8 | 15.8 | 3.8 | 56.5 | 43/43 (100) | 0/43 (0) | Stent migration, fistula, bleeding (no. of cases not listed) |
Alazmi et al. (2006) [20] | 148 | 3 | 2.5 | 3 | 32 | 131/148 (89) | 24/131 (18) | - |
Pasha et al. (2007) [21] | 25 | 2 | 4.65 | 3.5 | 21.5 | 22/25 (88) | 2/22 (9) | 5/105 ERC (4.8%): pancreatitis, fever, stent migration, hypoxia |
Holt et al. (2007) [17] | 53 | 11 | 3 | 18 | 34/53 (63) | 1/34 (3) | 11/53 Patients (20%): pancreatitis, minor complications (not listed) | |
Morelli et al. (2008) [15] | 38 | 2.5 | 3.5 | 3.45 | 12 | 33/38 (87) | 5/33 (15) | 2/38 Patients (5%): cholangitis |
Tabibian et al. (2010) [18] | 69 | 2.5 | 15 | 4.2 | 11 | 65/69 (94) | 2/65 (3) | 4/268 ERC (1.5%): pancreatitis, bacteremia |
Albert et al. (2013) [22] | 47 | 2.5 | 28 | 4.2 | 36 | 26/47 (63) | 15/41 (37) | 32/198 ERC (16%): cholangitis, pancreatitis, bleeding, perforation |
Poley et al. (2013) [23] | 31 | 4 | - | 5 | 28 | 25/31 (80) | - | 21/31 Patients (67%): cholangitis, pancreatitis, cholestasis |
ERC, endoscopic retrograde cholangiography; F/U, follow-up; AS, anastomotic stricture.